• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Identification and validation of clinical predictors for the risk of neurological involvement in children with HFMD in Sarawak

Shiloh

Editor, Senior Moderator
Source: http://7thspace.com/headlines/30217...h_hand_foot_and_mouth_disease_in_sarawak.html

Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak

Human enterovirus 71 (HEV71) can cause Hand, foot, and mouth disease (HFMD) with neurological complications, which may rapidly progress to fulminant cardiorespiratory failure, and death. Early recognition of children at risk is the key to reduce acute mortality and morbidity.

Methods: We examined data collected through a prospective clinical study of HFMD conducted between 2000 and 2006 that included 3 distinct outbreaks of HEV71 to identify risk factors associated with neurological involvement in children with HFMD.

Results: Total duration of fever for more than or equal to 3 days, peak temperature greater than or equal to 38.5oC and history of lethargy were identified as independent risk factors for neurological involvement (evident by CSF pleocytosis) in the analysis of 725 children admitted during the first phase of the study. When they were validated in the second phase of the study, two or more risk factors were present in 162 (65%) of 250 children with CSF pleocytosis compared with 56 (30%) of 186 children with no CSF pleocytosis (OR 4.27, 95% CI2.79-6.56, p<0.0001).

The usefulness of the three risk factors in identifying children with CSF pleocytosis on hospital admission during the second phase of the study was also tested. Peak temperature greater than or equal to 38.5oC and history of lethargy had the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 28%(48/174), 89%(125/140), 76%(48/63) and 50%(125/251), respectively in predicting CSF pleocytosis in children that were seen within the first 2 days of febrile illness.

For those presented on the 3rd or later day of febrile illness, the sensitivity, specificity, PPV and NPV of two or more risk factors predictive of CSF pleocytosis were 75%(57/76), 59%(27/46), 75%(57/76) and 59%(27/46), respectively.

Conclusion: Three readily elicited clinical risk factors were identified to help detect children at risk of neurological involvement.

These risk factors may serve as a guide to clinicians to decide the need for hospitalization and further investigation, including cerebrospinalfluid examination, and close monitoring for disease progression in children with HFMD.

Author: Mong How Ooi, See Chang Wong, Anand Mohan, Yuwana Podin, David Perera, Daniella Clear, Sylvia del Sel, Chae Hee Chieng, Phaik Hooi Tio, Mary Jane Cardosa and Tom Solomon
Credits/Source: BMC Infectious Diseases 2009, 9:3
 
Back
Top